GetTopicDetailResponse(id=f90b12934e80, topicName=工程化B細胞, introduction=, content=細胞療法 工程化B細胞, image=null, comments=0, allHits=21, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Aug 16 12:03:04 CST 2025, time=2025-08-16, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=507440, tagList=[TagDto(tagId=507440, tagName=工程化B細胞)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2277440, encodeId=f15f22e7440d8, content=<a href='/topic/show?id=3dcae7970d0' target=_blank style='color:#2F92EE;'>#細胞療法#</a> <a href='/topic/show?id=f90b12934e80' target=_blank style='color:#2F92EE;'>#工程化B細胞#</a>, objectTitle=Nature Biotechnology：當CAR-T遇到瓶頸，誰是下一個破局者？工程化B細胞，掀起細胞療法的第二次革命, objectType=article, longId=891975, objectId=7f6c8919e514, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668019090215_4754896.png, objectUrl=/article/show_article.do?id=7f6c8919e514, replyNumber=0, likeNumber=15, createdTime=2025-08-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7f6c8919e514, moduleTitle=Nature Biotechnology：當CAR-T遇到瓶頸，誰是下一個破局者？工程化B細胞，掀起細胞療法的第二次革命, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7f6c8919e514)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-08-16發(fā)表于上海
